Sign in
JWCTF Stock Price, Chart, Stats & News
JW (Cayman) Therapeutics Co. Ltd
Save
JW (Cayman) Therapeutics Co. Ltd (JWCTF) does not currently pay a dividend.
84.22M
Market cap
–
Current P/E
–
Forward P/E
JWCTF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
JW (Cayman) Therapeutics Co. Ltd is a biopharmaceutical entity currently in the clinical development phase, dedicated to the discovery, manufacturing, and commercialization of advanced cell-based immunotherapeutic solutions. Its core mission is to combat both hematological cancers (blood cancers) and various solid tumors.
Similar securities
Based on sector and market capitalization
Report issue